association

Full identifier: http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#association

Assigned to 1 class:

Minted in Nanopublication

 RASrQxw3sy comment approve/disapprove edit as derived nanopublication create new with same template

This is the identifier for this whole nanopublication. http://purl.org/np/RASrQxw3sy... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-08-25T13:58:13.360+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RASrQxw3sy... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAhNHZw6Ur... RAhNHZw6Ur .
This is the identifier for this whole nanopublication. http://purl.org/np/RASrQxw3sy... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RASrQxw3sy... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:58:13.360Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
"The use of Zileuton Extended-Release Tablets is contraindicated in patients with: Active liver disease or persistent hepatic function enzyme elevations greater than or equal to 3 times the upper limit of normal (>=3xULN) [see Warnings and Precautions (5) Use in Specific Populations (8.7) A history of allergic reaction to zileuton or any of the ingredients of Zileuton Extended Release Tablets (e.g., rash, eosinophilia, etc.). Active liver disease or persistent hepatic function enzyme elevations >=3 times the upper limit of normal. ( 4 5.1 History of allergic reaction to Zileuton or any of the ingredients of Zileuton Extended-Release Tablets. ( 4"
Leoni Bücken
2021-08-25T11:58:13.360Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:58:13.360Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:58:13.360Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:58:13.360Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:58:13.360Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:58:13.360Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)